Harvei S, Tretli S, Langmark F
Cancer Registry of Norway, Institute of Epidemiological Cancer Research, Oslo.
Eur J Cancer. 1996 Jan;32A(1):104-10. doi: 10.1016/0959-8049(95)00501-3.
Completeness of reporting and internal validity of the coding of prostate cancer in the Cancer Registry (CR) in Norway were examined. Data were matched and evaluated against diagnostic indices at eight selected hospitals in the country and against death certificates from Statistics Norway. Validity control was based on detailed re-analysis of an approximately 1% sample of the registered data during the period 1957-1986. The deficiency in reporting of prostate cancer was less than 1%. The grave deficiencies in hospital patient registers were considered to be of non-systematic nature and should, therefore, not impair the reliability of our investigation of incompleteness. The validity control revealed errors in 0.5% of the data elements, or, illustrated differently, 6% of the patient files had an error, of importance or not, in one of the data elements. One false positive registration was found among 298 controlled patient files (0.3%).
对挪威癌症登记处(CR)前列腺癌报告的完整性及编码的内部有效性进行了检查。将数据与该国八家选定医院的诊断指标以及挪威统计局的死亡证明进行匹配和评估。有效性控制基于对1957 - 1986年期间约1%的注册数据样本进行详细重新分析。前列腺癌报告的不足率低于1%。医院患者登记册中的严重不足被认为是非系统性的,因此不应损害我们对不完整性调查的可靠性。有效性控制显示0.5%的数据元素存在错误,或者换个说法,6%的患者档案在某一数据元素中存在重要或不重要的错误。在298份受控患者档案中发现1例假阳性登记(0.3%)。